These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 6947406)

  • 21. [Clinical pharmacokinetics of azlocillin].
    Singlas E; Haegel C
    Presse Med; 1984 Mar; 13(13):788-96. PubMed ID: 6231596
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Azlocillin and mezlocillin: two new semisynthetic acylureido-penicillins (author's transl)].
    Lode H; Niestrath U; Koeppe P; Langmaack H
    Infection; 1977; 5(3):163-9. PubMed ID: 334673
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Review of the pharmacokinetics and dose dependency of azlocillin in normal subjects and patients with renal insufficiency.
    Bergan T
    J Antimicrob Chemother; 1983 May; 11 Suppl B():101-14. PubMed ID: 6352598
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Pediatric pharmacology of azlocilin (author's transl)].
    Sitka U; Weingärtner L; Patsch R; Richter I
    Padiatr Padol; 1979; 14(4):429-40. PubMed ID: 530731
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinical experience with azlocillin in the treatment of urinary tract infections with Pseudomonas aeruginosa.
    Vestin L; Burman LA; Holm S; Sellers J
    Scand J Infect Dis; 1982; 14(4):289-91. PubMed ID: 7163781
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pharmacokinetics of azlocillin in children with cystic fibrosis.
    Bergan T; Michalsen H
    Arzneimittelforschung; 1979; 29(12a):1955-7. PubMed ID: 543899
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Pharmacokinetics of azlocillin in the burn patient].
    Drugeon HB; Pannier M; Courtieu AL
    Presse Med; 1984 Mar; 13(13):805-7. PubMed ID: 6231599
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Evaluation of amoxycillin--a new semisynthetic penicillin.
    Sabto J; Carson P; Morgan T
    Med J Aust; 1973 Sep; 2(11):537-41. PubMed ID: 4748581
    [No Abstract]   [Full Text] [Related]  

  • 29. Disposition of didanosine in HIV-seropositive patients with normal renal function or chronic renal failure: influence of hemodialysis and continuous ambulatory peritoneal dialysis.
    Knupp CA; Hak LJ; Coakley DF; Falk RJ; Wagner BE; Raasch RH; van der Horst CM; Kaul S; Barbhaiya RH; Dukes GE
    Clin Pharmacol Ther; 1996 Nov; 60(5):535-42. PubMed ID: 8941026
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Azlocillin--synovial fluid levels after intravenous doses].
    Härle A; Ritzerfeld W; Wiynck G; Knoche U
    Z Orthop Ihre Grenzgeb; 1983; 121(1):6-9. PubMed ID: 6405553
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pharmacokinetics of azlocillin in normal renal function: single and repetitive dosing studies.
    Delgado FA; Stout RL; Whelton A
    J Antimicrob Chemother; 1983 May; 11 Suppl B():79-88. PubMed ID: 6619035
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Azlocillin with and without an aminoglycoside against respiratory tract infections in children with cystic fibrosis.
    Michalsen H; Bergan T
    Scand J Infect Dis Suppl; 1981; 29():92-7. PubMed ID: 6947408
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Azlocillin pharmacokinetics in patients with cystic fibrosis.
    Bosso JA; Saxon BA; Herbst JJ; Matsen JM
    Antimicrob Agents Chemother; 1984 May; 25(5):630-2. PubMed ID: 6732230
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [On the excretion of azlocillin with bronchial secretion in children (author's transl)].
    Weingärtner L; Sitka U; Patsch R; Richter I; Thiemann HH
    Arzneimittelforschung; 1979; 29(12a):1952-4. PubMed ID: 543898
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [The biliary excretion of azlocillin].
    Düben W; Helwing E; Tettenborn D; Förster D; Pütter J
    Fortschr Med; 1979 Mar; 97(9):419-21. PubMed ID: 428879
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Evaluation of the clinical activity of azlocillin. A multicenter study conducted in 14 centers].
    Konopka CA
    Presse Med; 1984 Mar; 13(13):808-11. PubMed ID: 6231600
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Netilmicin treatment of complicated urinary tract infections.
    Madsen PO; Baumueller A; Frimodt-Møller N; Hoyme U; Lau C; Maigaard S; Nielsen OS; Welling PG
    Scand J Infect Dis Suppl; 1980; Suppl 23():128-31. PubMed ID: 6937956
    [TBL] [Abstract][Full Text] [Related]  

  • 38. No need to adjust the dose of 311C90 (zolmitriptan), a novel anti-migraine treatment, in patients with renal failure not requiring dialysis.
    Gillotin C; Bagnis C; Mamet JP; Peck RW; Deray G
    Int J Clin Pharmacol Ther; 1997 Nov; 35(11):522-6. PubMed ID: 9401835
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [The effect of hemodialysis and continuous ambulatory peritoneal dialysis on renal anemia].
    Stojimirović B; Grujić-Adanja G
    Srp Arh Celok Lek; 1997; 125(5-6):163-7. PubMed ID: 9265238
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pharmacokinetic aspects of digoxin in patients with terminal renal failure. I. Off dialysis.
    van der Vijgh WJ
    Int J Clin Pharmacol Biopharm; 1977 Jun; 15(6):249-54. PubMed ID: 881276
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.